Hillsdale Investment Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $867K | Sell |
24,050
-700
| -3% | -$25.2K | 0.03% | 324 |
|
|
2025
Q1 | $770K | Buy |
24,750
+500
| +2% | +$15.6K | 0.04% | 286 |
|
|
2024
Q4 | $619K | Buy |
24,250
+600
| +3% | +$15.3K | 0.03% | 338 |
|
|
2024
Q3 | $669K | Buy |
23,650
+3,500
| +17% | +$99K | 0.05% | 326 |
|
|
2024
Q2 | $531K | Hold |
20,150
| – | – | 0.04% | 325 |
|
|
2024
Q1 | $612K | Buy |
20,150
+2,900
| +17% | +$88.1K | 0.05% | 280 |
|
|
2023
Q4 | $485K | Buy |
17,250
+1,850
| +12% | +$52K | 0.04% | 314 |
|
|
2023
Q3 | $418K | Buy |
15,400
+2,600
| +20% | +$70.6K | 0.04% | 309 |
|
|
2023
Q2 | $393K | Buy |
12,800
+1,300
| +11% | +$40K | 0.04% | 295 |
|
|
2023
Q1 | $414K | Hold |
11,500
| – | – | 0.04% | 367 |
|
|
2022
Q4 | $454K | Buy |
11,500
+100
| +0.9% | +$3.95K | 0.04% | 368 |
|
|
2022
Q3 | $458K | Buy |
+11,400
| New | +$458K | 0.04% | 343 |
|